Experimental Neurology
Journal
Overview
publication venue for
-
Sex and age differentially affect GABAergic neurons in the mouse prefrontal cortex and hippocampus following chronic intermittent hypoxia.
325.
2020
-
Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminal.
318:251-257.
2019
-
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.
306:22-33.
2018
-
Cutaneous tissue damage induces long-lasting nociceptive sensitization and regulation of cellular stress- and nerve injury-associated genes in sensory neurons.
283:413-27.
2016
-
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome.
273:24-35.
2015
-
Large animal and primate models of spinal cord injury for the testing of novel therapies.
269:154-68.
2015
-
Commentary on Myers et al.: Growing role of the innate immunity receptor CD36 in central nervous system diseases.
261:633-7.
2014
-
Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor.
249:111-9.
2013
-
Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model.
248:491-503.
2013
-
Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - How much is enough?.
248:30-44.
2013
-
Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.
240:44-56.
2013
-
Corticotropin-releasing factor in the mouse central nucleus of the amygdala: Ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.
239:120-32.
2013
-
Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy.
237:180-90.
2012
-
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.
237:147-52.
2012
-
The NMDA-NR1 receptor subunit and the mu-opioid receptor are expressed in somatodendritic compartments of central nucleus of the amygdala neurons projecting to the bed nucleus of the stria terminalis.
234:112-26.
2012
-
Ovarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites.
230:186-96.
2011
-
Correlation between fetal brain activity patterns and behavioral states: An exploratory fetal magnetoencephalography study.
228:200-5.
2011
-
Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: Effects on brain cytokines and neurotrophins.
228:30-40.
2011
-
Chronic dizocilpine or apomorphine and development of neuropathy in two rat models I: Behavioral effects and role of nucleus accumbens.
228:19-29.
2011
-
Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.
227:149-58.
2011
-
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease.
225:74-84.
2010
-
Chronic intermittent hypoxia reduces neurokinin-1 (NK1) receptor density in small dendrites of non-catecholaminergic neurons in mouse nucleus tractus solitarius.
223:634-44.
2010
-
Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy.
223:245-50.
2010
-
Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.
220:191-7.
2009
-
Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons.
219:319-27.
2009
-
Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons.
218:274-85.
2009
-
Quinpramine is a novel compound effective in ameliorating brain autoimmune disease.
215:397-400.
2009
-
Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice.
213:57-70.
2008
-
Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis.
213:18-27.
2008
-
Angiotensin II-induced hypertension differentially affects estrogen and progestin receptors in central autonomic regulatory areas of female rats.
212:393-406.
2008
-
Intracellular and extracellular expression of the major inducible 70kDa heat shock protein in experimental ischemia-reperfusion injury of the spinal cord.
212:275-84.
2008
-
Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.
211:311-4.
2008
-
Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens.
210:750-61.
2008
-
Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment.
210:368-74.
2008
-
Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression.
209:268-78.
2008
-
Changes in the subcellular distribution of NADPH oxidase subunit p47phox in dendrites of rat dorsomedial nucleus tractus solitarius neurons in response to chronic administration of hypertensive agents.
205:383-95.
2007
-
Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.
205:74-81.
2007
-
Reversible attenuation of neuropathic-like manifestations in rats by lesions or local blocks of the intralaminar or the medial thalamic nuclei.
204:205-19.
2007
-
The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice.
200:166-71.
2006
-
Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: Evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells.
199:156-78.
2006
-
Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury.
199:179-90.
2006
-
Is ALS a systemic disorder? Evidence from muscle mitochondria.
198:1-3.
2006
-
Combined delivery of neurotrophin-3 and NMDA receptors 2D subunit strengthens synaptic transmission in contused and staggered double hemisected spinal cord of neonatal rat.
197:347-52.
2006
-
Transient attenuation of neuropathic manifestations in rats following lesion or reversible block of the lateral thalamic somatosensory nuclei.
197:157-66.
2006
-
Redistribution of mu-opioid receptors in C1 adrenergic neurons following chronic administration of morphine.
196:365-72.
2005
-
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
191:331-6.
2005
-
A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.
191:86-93.
2005
-
Evidence that infiltrating neutrophils do not release reactive oxygen species in the site of spinal cord injury.
190:414-24.
2004
-
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
188:491-4.
2004
-
Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity.
188:161-70.
2004
-
Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235.
183:673-81.
2003
-
Hilar neuropeptide Y interneuron loss in the aged rat hippocampal formation.
183:147-58.
2003
-
Increased μ-opioid receptor labeling is found on inner molecular layer terminals of the dentate gyrus following seizures.
179:200-9.
2003
-
Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in ρ0 cells.
179:229-35.
2003
-
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease.
178:13-20.
2002
-
Role of Fcγ receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia Nigra.
176:322-7.
2002
-
Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid.
176:262-5.
2002
-
Neurons with mu opioid receptors interact indirectly with enkephalin-containing neurons in the rat dentate gyrus.
176:254-61.
2002
-
Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei.
171:235-45.
2001
-
Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice.
168:419-24.
2001
-
Enhancement of laminar FosB expression in frontal cortex of rats receiving long chronic clozapine administration.
168:392-401.
2001
-
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.
168:356-63.
2001
-
Further evidence for mitochondrial dysfunction in progressive supranuclear palsy.
168:196-8.
2001
-
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.
167:189-95.
2001
-
Absence of p53: No effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
165:184-90.
2000
-
Selective agenesis of mesencephalic dopaminergic neurons in Nurr1- deficient mice.
159:451-8.
1999
-
Creatine and cyclocreatine attenuate MPTP neurotoxicity.
157:142-9.
1999
-
Novel free radical spin traps protect against malonate and MPTP neurotoxicity.
157:120-6.
1999
-
Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats.
154:673-83.
1998
-
Azulenyl nitrone spin traps protect against MPTP neurotoxicity.
152:163-6.
1998
-
Induction of calcitonin gene-related peptide-like immunoreactivity in hippocampal neurons following ischemia: A putative regional modulator of the CNS injury/immune response.
150:195-205.
1998
-
Adenovirus Vector-Mediated Gene Transfer into Human Epileptogenic Brain Slices: Prospects for Gene Therapy in Epilepsy.
148:167-78.
1997
-
Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line.
146:354-60.
1997
-
MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress.
144:193-8.
1997
-
S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity.
143:282-6.
1997
-
A quantitative spatial analysis of the blood-spinal cord barrier I. Permeability changes after experimental spinal contusion injury.
142:258-75.
1996
-
A quantitative spatial analysis of the blood-spinal cord barrier II. Permeability after intraspinal fetal transplantation.
142:226-43.
1996
-
Fetal Transplantation Following Spinal Contusion Injury Results in Chronic Alterations in CNS Glucose Metabolism.
133:231-43.
1995
-
Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency.
134:64-72.
1995
-
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity.
132:279-83.
1995
-
Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: Implications for gene targeting.
130:127-40.
1994
-
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum.
128:172-80.
1994
-
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
129:175-82.
1994
-
Intrastriatal injections of quinolinic acid or kainic acid: Differential patterns of cell survival and the effects of data analysis on outcome.
124:274-82.
1993
-
Tyrosine Hydroxylase Immunoreactivity and Monoamine and Metabolite Levels in Cryopreserved Human Fetal Ventral Mesencephalon.
121:172-80.
1993
-
Excitotoxin lesions in primates as a model for Huntington's disease: Histopathologic and neurochemical characterization.
119:46-71.
1993
-
Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism.
120:89-94.
1993
-
Extracellular proteins of goldfish optic tectum labeled by intraocular injection of 3H-proline.
117:260-8.
1992
-
Immunochemical studies of extracellular glycoproteins (X-GPs) of goldfish brain.
118:275-83.
1992
-
Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: Implications for the pathogenesis of neuroleptic-induced movement disorders.
117:17-27.
1992
-
Immunofluorescent characterization of retinal ganglion cell neurites cultured on substrates coated with antibodies against Thy-1.
113:386-90.
1991
-
Cryopreservation of human brain tissue.
107:208-13.
1990
-
Morphological and electrophysiological studies of human hippocampal transplants in the anterior eye chamber of athymic nude rats.
104:162-71.
1989
-
Stimulation of sciatic nerve regeneration in the adult rat by low-intensity electric current.
98:222-32.
1987
-
Nucleolar changes in goldfish retinal ganglion cells in response to an optic nerve lesion are not perturbed by a second lesion.
89:461-4.
1985
-
Local application of calcium-modulating agents to a crushed goldfish optic nerve modifies visual recovery.
83:403-13.
1984
-
Effect of traumatic injury on membrane phosphatase activity in cat spinal cord.
82:650-62.
1983
-
Bidirectional axonal transport of glycoproteins in goldfish optic nerve.
75:191-207.
1982
-
Intracranial transection of the optic nerve in adult mice: Preliminary observations.
76:318-30.
1982
-
Sciatic nerve regeneration in ganglioside-treated rats.
77:230-5.
1982
-
Electrophysiology of human muscle in culture.
72:281-93.
1981
-
Recovery of vision in regeneration of goldfish optic axons: Enhancement of axonal outgrowth by a conditioning lesion.
72:672-86.
1981
-
Methylation of erythrocyte membrane phospholipids in patients with myotonic and Duchenne muscular dystrophy.
70:380-91.
1980
-
Sprouting of sympathetic axons in the hippocampal formation: Conditions necessary to elicit ingrowth.
67:399-41.
1980
-
Denervation alterations in surface membrane glycoprotein glycosyltransferases of mammalian skeletal muscle.
61:432-41.
1978
-
β-Adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane.
59:361-71.
1978
-
Axonal transport and transneuronal transfer in mouse visual system following injection of [3H]fucose into the eye.
54:352-68.
1977
-
Development of denervation alterations in surface membranes of mammalian skeletal muscle.
56:102-14.
1977
-
Axonal transport of phospholipid in goldfish optic system.
46:261-81.
1975
-
Neuronal recognition and synaptogenesis.
48:52-74.
1975
-
The nerve cell body response to axotomy.
48:32-51.
1975
-
Regeneration after nerve transection: Effect of inhibition of collagen synthesis.
45:72-8.
1974
-
Accumulation of radioactive protein in mouse cerebral cortex after injection of 3H-fucose into the eye.
41:705-22.
1973
-
Effects of denervation on glycoproteins of rabbit gastrocnemius and soleus muscles.
39:58-69.
1973
-
Transport of radioactivity from eye to visual cortex in the mouse.
39:44-57.
1973
-
Effects of temperature on axonal transport and turnover of protein in goldfish optic system.
34:158-70.
1972
-
Transport of protein in goldfish optic nerve during regeneration.
25:494-508.
1969
-
Changes in the morphology and amino acid incorporation of regenerating goldfish optic neurons.
23:544-60.
1969
-
Corrigendum to "Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - How much is enough?" [Exp. Neurol. 248 (2013) 30-44].
248:299-300.
2013
-
Novel crosstalk between G protein-coupled receptors and NMDA receptors.
183:269-72.
2003
-
Research on recovery from CNS injury.
107:111-2.
1990
-
Cellular mechanisms for recovery from nervous system injury: A conference report.
71:6-75.
1981
-
Cellular mechanisms in axonal growth.
64:649-98.
1979
-
The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis
2008
-
Strategies for modulating Trk receptor activity
1993
-
Can Neurotrophic Factors Prevent or Reverse Motoneuron Injury in Amyotrophic Lateral Sclerosis?
1993
-
Dissecting DBS Dynamics through quantitative behavioral assessments and statistical modeling: A commentary on Cooper et al. 2011
2012
-
Ameliorating human diabetic neuropathy: Lessons from implanting hematopoietic mononuclear cells
2006
-
Commentary on "Alpha-synuclein and mitochondria: A tangled skein"
2004
Identity
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)